![logo](/logos/ENZ.webp)
Enzo Biochem, Inc.
NYSE:ENZ
1.12 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Enzo Biochem, Inc. |
Symbool | ENZ |
Munteenheid | USD |
Prijs | 1.12 |
Beurswaarde | 57,632,624 |
Dividendpercentage | 0% |
52-weken bereik | 0.99 - 1.5 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Kara Cannon |
Website | https://www.enzo.com |
An error occurred while fetching data.
Over Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)